Detalhe da pesquisa
1.
Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum.
Clin Infect Dis
; 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180851
2.
A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, "the Nevirapine Repeat Pregnancy study".
BMC Public Health
; 15: 988, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26420040